Integer Holdings Shares Plunge After Customers Defer Adoption of New Products

Dow Jones
2025/10/23

By Paul Ziobro

 

Shares of Integer Holdings posted its largest single-day drop on record after the medical device company issued a downbeat outlook, citing a number of customer order updates that will dent sales.

The stock was recently down 36.3% to $69.56, putting it on pace for the largest daily decrease on record, going back to 2000. Shares are down almost 45% this year.

The Plano, Texas-based company earlier Thursday cut its outlook for this year, despite posting better-than-expected profit and revenue for the third quarter, and issued preliminary guidance for next year below Wall Street expectations.

Chief Operating Officer Payman Khales said on Thursday's earnings call that a number of customers provided updates regarding the adoption of new products that will impact the next three quarters. "The magnitude of these changes on multiple products at the same time is highly unusual," said Khales, who in April was named the company's next chief executive, an appointment effective Friday.

For the current year, Integer trimmed its outlook slightly. It now expects sales to rise 7% to 8%, versus its prior view of 8% to 9% growth, while adjusted earnings is now expected to be $6.29 to $6.43, down from $6.25 to $6.51.

For next year, Integer forecast sales between a 2% decline and 2% gain and adjusted per-share earnings to either fall up to 6% or rise up to 5%. Analysts polled by FactSet were looking for sales to rise 7.4% and adjusted earnings to increase 12.1% on a per-share basis.

The company expects that despite the slowdown next year, its strategy and product development pipeline will help restore organic sales growth that is 200 basis points above market in 2027.

 

Write to Paul Ziobro at paul.ziobro@wsj.com

 

(END) Dow Jones Newswires

October 23, 2025 10:59 ET (14:59 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10